Devices › Device types
FDA product code OZD · class 3 · Unknown
Temporary non-roller type left heart support blood pump: medical device reports filed with FDA
45,326 reports carry this product code, 2016–2026; 17 brands with a page.
- 45,326
- reports with this product code
- 0.2% of all MAUDE reports
- 14,994
- reports, 12 months to August 2026
- 13,009 in the 12 months before
- 38%
- classified as malfunction
- 62.3% across all reports
- 12.8%
- classified as death, as reported
- 0.9% across all reports
Product code OZD is FDA's classification for "Temporary non-roller type left heart support blood pump" (unknown panel), a class 3 device. 45,326 medical device reports carry this product code, 0.2% of the MAUDE database, from February 2016 to August 2026.
14,994 reports arrived in the 12 months to August 2026, up 15% from 13,009 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (49.2%), malfunction (38%) and death (12.8%). 17 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Impella CP | 20,560 | 2,463 | 12.9% | 27.8% |
| Impella | 7,952 | 8,251 | 15.2% | 40.4% |
| Impella 5.5 | 7,578 | 1,640 | 12.5% | 41.7% |
| Automated Impella Controller | 3,740 | 455 | 5.6% | 93.4% |
| Pump 381 Pump Set (US) | 795 | 795 | 26.2% | 9.9% |
| Impella 5 0 | 624 | 3 | 22.3% | 32.8% |
| Impella 5.5 with SmartAssist S2 Set, US | 578 | 578 | 19.6% | 18.9% |
| Impella 2 5 | 320 | 0 | 11.9% | 33% |
| Impella Cp Optical | 248 | 0 | 8.1% | 5.6% |
| Automated Impella Controller Aic | 222 | 0 | 3.6% | 95.1% |
| Pump 371 14f Lt Cmr Set | 210 | 210 | 23.3% | 14.8% |
| Impella Cp Pump | 180 | 0 | 5% | 9.9% |
| Impella Cp Pump Set | 165 | 0 | 3.6% | 1.2% |
| Purge Cassette Gen 2, Sterile, Non QSK | 159 | 183 | 8.7% | 83.1% |
| Kit, 14Fr Introducer, 13cm&25cm, Sterile | 32 | 396 | 8.7% | 30.7% |
| Impella RP Flex | 13 | 173 | 19.5% | 34.9% |
| Impella Rp | 5 | 94 | 14.9% | 42% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Abiomed | 34,727 | 76.6% |
| Abiomed - 1220648 | 10,177 | 22.5% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Device sensing problem | 3,151 | 7% |
| Restricted flow rate | 3,116 | 6.9% |
| Patient device interaction problem | 2,873 | 6.3% |
| Patient-device incompatibilitythe device did not suit the patient | 2,043 | 4.5% |
| Pumping stopped | 1,804 | 4% |
| Malposition of device | 1,709 | 3.8% |
| Failure to advance | 1,688 | 3.7% |
| Application program problem | 1,552 | 3.4% |
| Increase in pressure | 1,542 | 3.4% |
| Positioning failure | 1,486 | 3.3% |
| Fluid/blood leak | 1,095 | 2.4% |
| Deformation due to compressive stress | 996 | 2.2% |
| Electrical /electronic property probleman electrical or electronic problem | 921 | 2% |
| Failure to read input signal | 840 | 1.9% |
| Battery problema problem with the battery | 711 | 1.6% |
| Activation, positioning or separation problem | 605 | 1.3% |
| Improper flow or infusion | 492 | 1.1% |
| Positioning problem | 491 | 1.1% |
| Material integrity problema problem with the device material | 465 | 1% |
| Priming problem | 412 | 0.9% |
Questions about temporary non-roller type left heart support blood pump reports
What is product code OZD?
FDA's classification code for "Temporary non-roller type left heart support blood pump", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.
How many reports carry this code?
45,326 reports through August 2026, 14,994 of them in the latest 12 months.
Which brands appear most often?
Impella CP (20,560), Impella (7,952), Impella 5.5 (7,578), Automated Impella Controller (3,740) and Pump 381 Pump Set (US) (795). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.